90 related articles for article (PubMed ID: 32674353)
1. Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma.
Rodríguez-Nogales C; Moreno H; Zandueta C; Desmaële D; Lecanda F; Couvreur P; Blanco-Prieto MJ
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674353
[TBL] [Abstract][Full Text] [Related]
2. Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice.
Rodríguez-Nogales C; Mura S; Couvreur P; Blanco-Prieto MJ
Int J Pharm; 2020 May; 582():119345. PubMed ID: 32311470
[TBL] [Abstract][Full Text] [Related]
3. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
Rodríguez-Nogales C; Sebastián V; Irusta S; Desmaële D; Couvreur P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2019 Nov; 144():165-173. PubMed ID: 31546021
[TBL] [Abstract][Full Text] [Related]
4. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.
Maksimenko A; Alami M; Zouhiri F; Brion JD; Pruvost A; Mougin J; Hamze A; Boissenot T; Provot O; Desmaële D; Couvreur P
ACS Nano; 2014 Mar; 8(3):2018-32. PubMed ID: 24555414
[TBL] [Abstract][Full Text] [Related]
6. Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.
Reddy LH; Marque PE; Dubernet C; Mouelhi SL; Desmaële D; Couvreur P
J Pharmacol Exp Ther; 2008 May; 325(2):484-90. PubMed ID: 18258784
[TBL] [Abstract][Full Text] [Related]
7. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
[TBL] [Abstract][Full Text] [Related]
8. Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane.
Ambike A; Rosilio V; Stella B; Lepêtre-Mouelhi S; Couvreur P
Langmuir; 2011 Apr; 27(8):4891-9. PubMed ID: 21413743
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma.
González-Fernández Y; Brown HK; Patiño-García A; Heymann D; Blanco-Prieto MJ
Cancer Lett; 2018 Aug; 430():193-200. PubMed ID: 29802930
[TBL] [Abstract][Full Text] [Related]
10. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis.
Ando T; Ichikawa J; Fujimaki T; Taniguchi N; Takayama Y; Haro H
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114161
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis.
Gaudin A; Lepetre-Mouelhi S; Mougin J; Parrod M; Pieters G; Garcia-Argote S; Loreau O; Goncalves J; Chacun H; Courbebaisse Y; Clayette P; Desmaële D; Rousseau B; Andrieux K; Couvreur P
J Control Release; 2015 Aug; 212():50-8. PubMed ID: 26087468
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled drug delivery systems. Part 8: In vitro/in vivo studies of the nanoassemblies of cholesteryl-phosphonyl gemcitabine.
Li M; Qi S; Jin Y; Dong J
Int J Pharm; 2015 Jan; 478(1):124-130. PubMed ID: 25448574
[TBL] [Abstract][Full Text] [Related]
14. Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts.
Anderson GS; Tsujino I; Miyagi K; Sampson R; Sieber F
J Photochem Photobiol B; 2003 Feb; 69(2):87-95. PubMed ID: 12633981
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.
Jin Y; Lian Y; Du L; Wang S; Su C; Gao C
Int J Pharm; 2012 Jul; 430(1-2):276-81. PubMed ID: 22486963
[TBL] [Abstract][Full Text] [Related]
16. Progress in the chemotherapeutic treatment of osteosarcoma.
Zhang Y; Yang J; Zhao N; Wang C; Kamar S; Zhou Y; He Z; Yang J; Sun B; Shi X; Han L; Yang Z
Oncol Lett; 2018 Nov; 16(5):6228-6237. PubMed ID: 30405759
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol Promotes Tumor Microvessel Growth via Endoglin and Extracellular Signal-Regulated Kinase Signaling Pathway and Enhances the Anticancer Efficacy of Gemcitabine against Lung Cancer.
Qin SH; Lau ATY; Liang ZL; Tan HW; Ji YC; Zhong QH; Zhao XY; Xu YM
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32326402
[TBL] [Abstract][Full Text] [Related]
18. CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome.
Gvozdenovic A; Arlt MJ; Campanile C; Brennecke P; Husmann K; Li Y; Born W; Muff R; Fuchs B
J Bone Miner Res; 2013 Apr; 28(4):838-47. PubMed ID: 23169460
[TBL] [Abstract][Full Text] [Related]
19. Role of aldolase A in osteosarcoma progression and metastasis: in vitro and in vivo evidence.
Long F; Cai X; Luo W; Chen L; Li K
Oncol Rep; 2014 Nov; 32(5):2031-7. PubMed ID: 25215901
[TBL] [Abstract][Full Text] [Related]
20. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum.
Gajate C; Matos-da-Silva M; Dakir el-H; Fonteriz RI; Alvarez J; Mollinedo F
Oncogene; 2012 May; 31(21):2627-39. PubMed ID: 22056873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
